Takeda China is the Chinese operation of Takeda, a global, research-driven biopharmaceutical company with more than 240 years of history. Guided by a patient-focused, values-based approach, the company aims to turn scientific and technological advances into medicines and therapies that address unmet healthcare needs and create value for society.

Takeda entered China in 1994 and is headquartered in Shanghai, with business centers in Beijing, Shanghai, Tianjin and Guangzhou, offices in major cities, and around 2,500 employees in the country. Its activities include research and development, clinical trials, manufacturing, supplier and logistics operations, and the provision of medicines available in China. The website also provides updated product information and approved medicine instructions for healthcare professionals.

China is an important strategic market for Takeda. The company’s local initiatives include the “Takeda China” strategy launched in 2022, following its earlier five-year “Together for the Future” plan. By 2025, more than 15 new products had been launched in China. Takeda China also shares company news, sustainability information, governance disclosures and contact resources.